Three Stocks That May Be Priced Below Their Estimated Value In July 2025

As the major U.S. stock indices, including the S&P 500 and Nasdaq, continue to reach record highs, investors are keenly observing earnings reports and geopolitical developments that could influence market dynamics. In this environment of heightened activity, identifying stocks that may be undervalued can offer potential opportunities for those looking to capitalize on discrepancies between a company's market price and its intrinsic value.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Name	Current Price	Fair Value (Est)	Discount (Est)
StoneCo (STNE)	$14.98	$29.30	48.9%
Rapid7 (RPD)	$22.56	$43.72	48.4%
Hess Midstream (HESM)	$38.18	$73.29	47.9%
Freshpet (FRPT)	$69.39	$133.26	47.9%
FB Financial (FBK)	$48.14	$93.90	48.7%
Definitive Healthcare (DH)	$4.02	$7.83	48.6%
Carter Bankshares (CARE)	$17.93	$35.50	49.5%
Camden National (CAC)	$41.89	$83.75	50%
ACNB (ACNB)	$43.09	$85.05	49.3%
Acadia Realty Trust (AKR)	$18.72	$36.72	49%

Click here to see the full list of 174 stocks from our Undervalued US Stocks Based On Cash Flows screener.

Let's take a closer look at a couple of our picks from the screened companies.

Aehr Test Systems (AEHR)

Overview: Aehr Test Systems, Inc. offers test solutions for semiconductor devices in various forms globally and has a market cap of approximately $419.77 million.

Operations: The company's revenue is primarily derived from the designing, manufacturing, and marketing of advanced test and burn-in products, totaling $58.97 million.

Estimated Discount To Fair Value: 21.3%

Aehr Test Systems is trading at US$14.78, below its estimated fair value of US$18.79, suggesting potential undervaluation. Despite a recent net loss of US$3.91 million for the year ending May 2025, its revenue growth forecast of 23.6% annually surpasses the broader U.S. market's expected rate of 8.9%. The company was recently added to multiple Russell Value Indexes, reflecting market recognition despite current profitability challenges and a low projected return on equity at 12.6%.

• The analysis detailed in our Aehr Test Systems growth report hints at robust future financial performance.
• Click here and access our complete balance sheet health report to understand the dynamics of Aehr Test Systems.

Comstock Resources (CRK)

Overview: Comstock Resources, Inc. is an independent energy company focused on acquiring, exploring, developing, and producing natural gas and oil properties in the United States with a market cap of $6.84 billion.

Operations: The company's revenue is primarily derived from its Oil & Gas - Exploration & Production segment, totaling $1.43 billion.

Estimated Discount To Fair Value: 26%

Comstock Resources, trading at US$23.34, is below its fair value estimate of US$31.55, indicating potential undervaluation based on cash flows. Despite a high debt level and recent net loss of US$121.28 million in Q1 2025, revenue grew to US$512.85 million from the previous year and is forecasted to grow faster than the U.S. market average at 16.8% annually. Recent additions to multiple Russell Growth Indexes highlight market interest amidst profitability challenges.

• Our earnings growth report unveils the potential for significant increases in Comstock Resources' future results.
• Unlock comprehensive insights into our analysis of Comstock Resources stock in this financial health report.

VTEX (VTEX)

Overview: VTEX, along with its subsidiaries, offers a software-as-a-service digital commerce platform for enterprise brands and retailers, with a market cap of approximately $1.19 billion.

Operations: The company's revenue is derived entirely from its Internet Software & Services segment, amounting to $228.24 million.

Estimated Discount To Fair Value: 35%

VTEX, trading at US$6.71, is undervalued compared to its estimated fair value of US$10.32, with earnings expected to grow significantly over the next three years. The company has recently turned profitable and forecasts annual revenue growth of 13.5%, exceeding the U.S. market average. Despite a low forecasted return on equity and large one-off items affecting results, VTEX's inclusion in multiple Russell Growth Indexes underscores its potential appeal to investors seeking undervalued opportunities based on cash flows.

• Our comprehensive growth report raises the possibility that VTEX is poised for substantial financial growth.
• Click here to discover the nuances of VTEX with our detailed financial health report.

Next Steps

• Embark on your investment journey to our 174 Undervalued US Stocks Based On Cash Flows selection here.
• Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
• Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Searching for a Fresh Perspective?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com